AKT1 and non-small cell lung carcinoma: Jin’s research indicated that the potential of CRTAC1 to augment the chemosensitivity of non-small cell lung cancer to cisplatin is attributed to its ability to induce RyR-mediated calcium release and suppress Akt1 expression12.